Zydus Lifesciences gets FDA final approval for Vigabatrin for Oral Solution
Zydus Lifesciences has bagged final approval for seizures drug Vigabatrin for Oral Solution USP, 500 mg from the US Food and Drug Administration (FDA). Vigabatrin ... Read More
Zydus Lifesciences gets FDA final approval for Acyclovir Cream
Zydus Lifesciences (formerly Cadila Healthcare) has secured final approval for Acyclovir Cream, 5% from the US Food and Drug Administration (FDA) Acyclovir Cream, 5% is ... Read More
Zydus Lifesciences bags FDA final approval for Apixaban Tablets
Zydus Lifesciences has bagged final approval from the US Food and Drug Administration (FDA) for Apixaban Tablets, 2.5mg and 5mg, a generic version of Eliquis ... Read More
Phoenix Mills, BSafal to open Palladium Ahmedabad shopping mall today
The Phoenix Mills Limited (PML), an Indian developer and operator of retail led mixed use developments, and BSafal Group are set to launch the Palladium ... Read More
Uber Technologies to procure 25,000 of XPREST EVs from Tata Motors
American ride hailing company Uber Technologies has signed a memorandum of understanding (MoU) with Tata Motors to bring 25,000 electric vehicles (EVs) onto its platform ... Read More
Zydus Hospitals, Medtronic launch AI-based stroke care network in Gujarat
Zydus Hospitals, Ahmedabad, and India Medtronic Private Limited, a fully-owned affiliate of American medical devices maker Medtronic announced a collaboration to help patients suffering from ... Read More
Vaxtex Cotfab reports Q3FY22 net sales of Rs 11,38 lakhs
Vaxtex Cotfab, an Indian textile manufacturing company, reported INR 11,38.71 lakhs in net sales for the third quarter that ended on 31 December 2022 (Q3FY22). ... Read More
Zydus Lifesciences gets FDA final approvals for Silodosin and Pregabalin capsules
Zydus Lifesciences (formerly known as Cadila Healthcare) has secured final approvals from the US Food and Drug Administration (FDA) for Silodosin Capsules, 4 mg and ... Read More
Zydus Lifesciences gets FDA approval for Estradiol Transdermal System
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day ... Read More
Zydus Lifesciences gets FDA final approval for BP drug generic version
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg ... Read More